All News | FDA

Advertising & Promotion

Jun 10, 2015
FDA Letter Blunts Amarin Lawsuit by Approving Some Off-label Claims
Jun 8, 2015
OMB OKs Planned FDA Research on Perceptions of Risk/Reward in DTC
Jun 4, 2015
FTC Hearing To Weigh Crackdown on Homeopathic Advertising
Jun 3, 2015
OMB Approves Planned Research on Drug Ads
May 29, 2015
Planned FDA Research on Spousal Influence Sent to OMB for Review
May 28, 2015
House Bill Pushes FDA To Permit Linked Risk Info in Online Ads
May 22, 2015
Not Going With the Flo: OPDP Chastises Actavis Over Website’s Promotional Claims
May 20, 2015
OPDP Blasts Company for Omitting Risk Information From Booth Banner
May 13, 2015
FDA Crafting New Disease Awareness Draft Guidance, No Timetable on Completion
May 11, 2015
Amarin Sues FDA Over Off-label Promotion Ban

Good Clinical Practice

Aug 11, 2016
CTTI Starts Program To Jumpstart Mobile Trials
Aug 11, 2016
CDER Revised List of 2016 Guidance Includes Clinical Research Topics
Aug 9, 2016
Investigator Charged with Insider Trading
Aug 5, 2016
FDA To Host Pediatric Master Protocol Workshop in September
Aug 5, 2016
Survey Finds Nearly Half of Pediatric Trials Go Unfinished or Unpublished
Aug 4, 2016
Investigator Group Calls for Longer Waiting Period for Data Sharing Than ICMJE Proposed
Aug 3, 2016
FDA-OHRP Provide IRB Written Procedure Checklist
Aug 1, 2016
CTTI Issues Recommendations for HABP/VABP Trials
Jul 29, 2016
Device Center Highlights EFS Considerations
Jul 28, 2016
FDA-CMS Looking to Simplify Device Coverage

FDA Regulation & Enforcement

Mar 21, 2019
Ill. House Approves Bill Prohibiting Sale of Prescribing Data for Marketing
Mar 21, 2019
OMB Reviewing DTC List Price Rule
Mar 21, 2019
OPDP Study Finds Extrinsic Cues Can Influence Consumer Choices
Mar 21, 2019
Petition Wants FDA to Revise Nutrient Content Regulations
Mar 20, 2019
DOJ Criminal Actions Target Illicit Dietary Supplements as FDA Develops New Enforcement Strategies
Mar 18, 2019
Maine Bill Considers Drug Cost Reporting
Mar 14, 2019
Health Canada Proposes More Restrictions on Marketing Class B Opioids to HPCs
Mar 13, 2019
Covidien’s $17.5 Million Settlement Resolves Kickback Allegations Related to Catheter Sales
Mar 13, 2019
USDA, FDA Provide Details on Sharing Oversight of Cell Cultured Food
Mar 12, 2019
Oregon Settles With Pfizer Over Coupons

Copyright © Thompson FDA, a division of CBIS. All rights reserved.